TRACC
11 Nov 2020
Trial Summary
An Australian, non-interventional registry to evaluate clinical outcomes and bevacizumab use in metastatic colorectal cancer from routine clinical practise.
Acronym:
TRACC
ACTRN/NCT /ethics:
NCT04050345
Scientific title:
Tracking Mutations in Cell Free Tumour DNA to Predict Relapse in Early Colorectal Cancer
Sponsor / Cooperative group:
Royal Marsden NHS Foundation Trust
Trial & Patient Characteristics
| Cancer Type | Bowel and colon |
|---|---|
| Trial Type | Early detection, diagnosis, prognosis |
| Phase | All phases |
| Age Range | 18 years and older |
| Sex | All |
| Tumour Stream | Colorectal |
| Cancer Stage | Metastatic or Widespread |
| Anticipated Start Date | N/A |
| Anticipated End Date | N/A |
Participating Hospitals
| Hospital | Mt Gambier General Hospital |
|---|---|
| Clinical Trial Coordinator | Jane Fuller |
| Jane.Fuller@sa.gov.au | |
| Phone | - |
| Principal Investigator | Dr Arwa Abdelomogod |
| Recruitment Status | Recruiting |